Literature DB >> 31279419

Cardiorenal Syndrome: Pathophysiology.

Ujjala Kumar1, Nicholas Wettersten2, Pranav S Garimella3.   

Abstract

Cardiorenal syndrome commonly refers to the collective dysfunction of heart and kidney resulting in a cascade of feedback mechanism causing damage to both the organs and is associated with adverse clinical outcomes. The pathophysiology of cardiorenal syndrome is complex, multifactorial, and dynamic. Improving the understanding of disease mechanisms will aid in developing targeted pharmacologic and nonpharmacologic therapies for the management of this syndrome. This article discusses the various mechanisms involved in the pathophysiology of the cardiorenal syndrome.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiorenal; Inflammatory mediators; Intra-abdominal pressure; Oxidative stress; RAAS; Uremic toxins; Venous congestion

Year:  2019        PMID: 31279419      PMCID: PMC6658134          DOI: 10.1016/j.ccl.2019.04.001

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  22 in total

Review 1.  Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.

Authors:  Feby Savira; Ruth Magaye; Danny Liew; Christopher Reid; Darren J Kelly; Andrew R Kompa; S Jeson Sangaralingham; John C Burnett; David Kaye; Bing H Wang
Journal:  Br J Pharmacol       Date:  2020-05-13       Impact factor: 8.739

2.  Vitamin D Binding Protein and Renal Injury in Acute Decompensated Heart Failure.

Authors:  Elisa Diaz-Riera; Maisa García-Arguinzonis; Laura López; Xavier Garcia-Moll; Lina Badimon; Teresa Padró
Journal:  Front Cardiovasc Med       Date:  2022-06-09

3.  Heart failure and acute renal dysfunction in the cardiorenal syndrome.

Authors:  Rajinder S Chahal; Chukwuma A Chukwu; Paul R Kalra; Philip A Kalra
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

4.  Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study.

Authors:  Wenguang Lai; Xiaoli Zhao; Zhidong Huang; Yun Xie; Sijia Yu; Jiabin Tu; Dachuan Guo; Jiaming Xiu; Ziling Mai; Qiang Li; Haozhang Huang; Huanqiang Li; Jun-Yan Xu; Hongyu Lu; Guanzhong Chen; Shiqun Chen; Jin Liu; Yong Liu
Journal:  J Inflamm Res       Date:  2022-05-13

5.  Impact of Transcatheter Aortic Valve Implantation on Kidney Function: the "Renovalvular" Interaction in Aortic Stenosis.

Authors:  Antonio de Santis
Journal:  Arq Bras Cardiol       Date:  2019-12       Impact factor: 2.000

Review 6.  OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention.

Authors:  Stephen J Peterson; Abu Choudhary; Amardeep K Kalsi; Shuyang Zhao; Ragin Alex; Nader G Abraham
Journal:  Diagnostics (Basel)       Date:  2020-11-20

7.  Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis.

Authors:  Grigorios Tsigkas; Anastasiοs Apostolos; Stefanos Despotopoulos; Georgios Vasilagkos; Angeliki Papageorgiou; Eleftherios Kallergis; Georgios Leventopoulos; Virginia Mplani; Ioanna Koniari; Dimitrios Velissaris; John Parissis
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

Review 8.  Evidence based review of management of cardiorenal syndrome type 1.

Authors:  Leong Tung Ong
Journal:  World J Methodol       Date:  2021-07-20

Review 9.  H2S- and NO-releasing gasotransmitter platform: A crosstalk signaling pathway in the treatment of acute kidney injury.

Authors:  Joana Claudio Pieretti; Carolina Victoria Cruz Junho; Marcela Sorelli Carneiro-Ramos; Amedea Barozzi Seabra
Journal:  Pharmacol Res       Date:  2020-08-14       Impact factor: 7.658

10.  A Clinical Association between an Increasing Renal Resistive Index and the Atherosclerotic Burden in Patients with a Preserved Renal Function.

Authors:  Ippei Watanabe; Yodo Shintani; Shigenori Terada; Takahiro Fujii; Shunsuke Kiuchi; Rine Nakanishi; Tomoyuki Katayanagi; Muneyasu Kawasaki; Keiichi Tokuhiro; Hidefumi Ohsawa; Takanori Ikeda
Journal:  Intern Med       Date:  2020-04-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.